Although our initial results suggested that CCR5 expressed on regulatory T cells may be associated with better suppressive effects in vitro, our subsequent results showed that CCR5 + Tregs in T1D diabetes are functionally deficient in suppression. This evidence concerns the gene CCR5 and type 1 diabetes mellitus.